Harm reduction, human rights and public health

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Despite vigorous efforts on the part of the international community, and an unprecedented level of research across an enormous variety of fields, HIV/AIDS has become the most severe infectious disease epidemic of modern times. HIV spread is either accelerating or remains stable at unacceptably high levels. Despite a relatively long list of prevention tools with good evidence for efficacy in HIV prevention, this domain has been marked by many failures and only a few successes by a tragic and ongoing history of inability to implement the tools available to control HIV spread. HIV spreads through sexual and reproductive behaviors and by blood and blood-products exposures, including sharing of injection equipment among drug users. The history of other sexually transmitted diseases suggests that most societies have been challenged in dealing pragmatically with diseases spread by sexual behavior. Intravenous drug users (IDUs) remain one of the most vulnerable groups for HIV infection. Prevention strategies for HIV infection can be divided into two main groups: harm-reduction strategies and a protective vaccine against HIV infection. And while it is important to include IDUs as study participants for HIV vaccine trials, harm-reduction strategies are currently the only proven way of preventing HIV infection. The immediate goal of harm-reduction strategies is not to reduce the use of drugs; instead it is to reduce the associated risk of HIV infection with drug use. Incarcerated populations remain among the most vulnerable for HIV infection worldwide because the burden of infectious disease in entrants to the penal system is significantly higher than in the general population, and in prison there is a heightened risk environment.

Original languageEnglish (US)
Title of host publicationHIV Prevention
PublisherElsevier Inc.
ISBN (Print)9780123742353
DOIs
StatePublished - 2009

Fingerprint

Harm Reduction
Public health
HIV Infections
Public Health
HIV
Drug Users
Pharmaceutical Preparations
Blood
Sexual Behavior
Communicable Diseases
Prisons
AIDS Vaccines
Reproductive Behavior
Sexually Transmitted Diseases
Vaccines
Population
Acquired Immunodeficiency Syndrome
History
Equipment and Supplies
Injections

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Harm reduction, human rights and public health. / Beyrer, Christopher; Sherman, Susan; Baral, Stefan.

HIV Prevention. Elsevier Inc., 2009.

Research output: Chapter in Book/Report/Conference proceedingChapter

@inbook{e3b1711cb78e4e21bb553a815e4d9f44,
title = "Harm reduction, human rights and public health",
abstract = "Despite vigorous efforts on the part of the international community, and an unprecedented level of research across an enormous variety of fields, HIV/AIDS has become the most severe infectious disease epidemic of modern times. HIV spread is either accelerating or remains stable at unacceptably high levels. Despite a relatively long list of prevention tools with good evidence for efficacy in HIV prevention, this domain has been marked by many failures and only a few successes by a tragic and ongoing history of inability to implement the tools available to control HIV spread. HIV spreads through sexual and reproductive behaviors and by blood and blood-products exposures, including sharing of injection equipment among drug users. The history of other sexually transmitted diseases suggests that most societies have been challenged in dealing pragmatically with diseases spread by sexual behavior. Intravenous drug users (IDUs) remain one of the most vulnerable groups for HIV infection. Prevention strategies for HIV infection can be divided into two main groups: harm-reduction strategies and a protective vaccine against HIV infection. And while it is important to include IDUs as study participants for HIV vaccine trials, harm-reduction strategies are currently the only proven way of preventing HIV infection. The immediate goal of harm-reduction strategies is not to reduce the use of drugs; instead it is to reduce the associated risk of HIV infection with drug use. Incarcerated populations remain among the most vulnerable for HIV infection worldwide because the burden of infectious disease in entrants to the penal system is significantly higher than in the general population, and in prison there is a heightened risk environment.",
author = "Christopher Beyrer and Susan Sherman and Stefan Baral",
year = "2009",
doi = "10.1016/B978-0-12-374235-3.00018-2",
language = "English (US)",
isbn = "9780123742353",
booktitle = "HIV Prevention",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Harm reduction, human rights and public health

AU - Beyrer, Christopher

AU - Sherman, Susan

AU - Baral, Stefan

PY - 2009

Y1 - 2009

N2 - Despite vigorous efforts on the part of the international community, and an unprecedented level of research across an enormous variety of fields, HIV/AIDS has become the most severe infectious disease epidemic of modern times. HIV spread is either accelerating or remains stable at unacceptably high levels. Despite a relatively long list of prevention tools with good evidence for efficacy in HIV prevention, this domain has been marked by many failures and only a few successes by a tragic and ongoing history of inability to implement the tools available to control HIV spread. HIV spreads through sexual and reproductive behaviors and by blood and blood-products exposures, including sharing of injection equipment among drug users. The history of other sexually transmitted diseases suggests that most societies have been challenged in dealing pragmatically with diseases spread by sexual behavior. Intravenous drug users (IDUs) remain one of the most vulnerable groups for HIV infection. Prevention strategies for HIV infection can be divided into two main groups: harm-reduction strategies and a protective vaccine against HIV infection. And while it is important to include IDUs as study participants for HIV vaccine trials, harm-reduction strategies are currently the only proven way of preventing HIV infection. The immediate goal of harm-reduction strategies is not to reduce the use of drugs; instead it is to reduce the associated risk of HIV infection with drug use. Incarcerated populations remain among the most vulnerable for HIV infection worldwide because the burden of infectious disease in entrants to the penal system is significantly higher than in the general population, and in prison there is a heightened risk environment.

AB - Despite vigorous efforts on the part of the international community, and an unprecedented level of research across an enormous variety of fields, HIV/AIDS has become the most severe infectious disease epidemic of modern times. HIV spread is either accelerating or remains stable at unacceptably high levels. Despite a relatively long list of prevention tools with good evidence for efficacy in HIV prevention, this domain has been marked by many failures and only a few successes by a tragic and ongoing history of inability to implement the tools available to control HIV spread. HIV spreads through sexual and reproductive behaviors and by blood and blood-products exposures, including sharing of injection equipment among drug users. The history of other sexually transmitted diseases suggests that most societies have been challenged in dealing pragmatically with diseases spread by sexual behavior. Intravenous drug users (IDUs) remain one of the most vulnerable groups for HIV infection. Prevention strategies for HIV infection can be divided into two main groups: harm-reduction strategies and a protective vaccine against HIV infection. And while it is important to include IDUs as study participants for HIV vaccine trials, harm-reduction strategies are currently the only proven way of preventing HIV infection. The immediate goal of harm-reduction strategies is not to reduce the use of drugs; instead it is to reduce the associated risk of HIV infection with drug use. Incarcerated populations remain among the most vulnerable for HIV infection worldwide because the burden of infectious disease in entrants to the penal system is significantly higher than in the general population, and in prison there is a heightened risk environment.

UR - http://www.scopus.com/inward/record.url?scp=84883932468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883932468&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-374235-3.00018-2

DO - 10.1016/B978-0-12-374235-3.00018-2

M3 - Chapter

SN - 9780123742353

BT - HIV Prevention

PB - Elsevier Inc.

ER -